mRNA Vaccine Clinical Trials in Chengdu, Sichuan
3 recruitingChengdu, Sichuan, China
Showing 1–3 of 3 trials
Recruiting
Phase 1
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
Solid Tumor CancerCancer, MetastaticmRNA Vaccine+1 more
West China Hospital18 enrolled1 locationNCT07583654
Recruiting
Phase 1
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
West China Hospital6 enrolled2 locationsNCT07040943
Recruiting
Phase 1
A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
Xingchen Peng6 enrolled1 locationNCT07100210